XPC rs2228000: What Your Genotype Means
The rs2228000 variant is a specific change in the XPC gene, which plays a vital role in repairing damaged DNA. Researchers study this variant to understand if it influences an individual's susceptibility to certain cancers or their response to DNA-damaging therapies.
What each genotype means
Typical DNA repair capacity
This genotype represents the most common form of the XPC gene in many populations. Research into how this specific variant influences DNA repair efficiency and chemotherapy response remains inconclusive, with some studies suggesting it may be associated with different cancer risk profiles compared to the T allele. Please discuss any concerns regarding treatment sensitivity or medication response with your clinician or pharmacist.
Carried by approximately 40-45% of individuals in many global populations, though frequencies vary significantly by ancestry.
Intermediate DNA repair variant
Carrying one copy of the T allele means you have a mix of the common and variant forms of the XPC gene. Scientific evidence regarding the functional impact of this variant on DNA repair and chemotherapy outcomes is currently limited and mixed across different studies. You should consult with your healthcare provider or pharmacist regarding any implications for your personal health or medication management.
This heterozygous genotype is common, appearing in roughly 40-50% of individuals in many populations.
Variant DNA repair profile
This genotype consists of two copies of the T allele, which results in the Ala499Val amino acid change in the XPC protein. While some research investigates whether this variant influences DNA repair efficiency and survival outcomes following DNA-damaging chemotherapy, the findings are not definitive and remain a subject of ongoing study. Always discuss your specific health profile and any potential medication responses with your clinician or pharmacist.
Carried by roughly 10-15% of individuals in many global populations, with higher frequencies observed in some South Asian groups.
What is rs2228000?
The rs2228000 variant is a single nucleotide polymorphism (SNP) located within the XPC gene on chromosome 3. In this specific location, the DNA sequence can feature either a cytosine (C) or a thymine (T). This change is often referred to as Ala499Val, indicating that the genetic variation results in an amino acid substitution of alanine to valine at position 499 of the XPC protein. Because this change occurs in the coding region of the gene, it has the potential to alter the structure or function of the resulting protein. Scientists track this variant to determine if these structural changes impact the body's ability to maintain genomic integrity, which is a fundamental process for preventing the accumulation of mutations that can lead to disease.
The Role of the XPC Gene
The XPC gene provides instructions for making a protein that is a critical component of the nucleotide excision repair (NER) pathway. This pathway is the body's primary mechanism for identifying and removing damaged segments of DNA, particularly those caused by environmental factors like ultraviolet radiation or certain chemical exposures. By recognizing distortions in the DNA double helix, the XPC protein initiates a cascade of repair activities that restore the genetic code to its correct state. When the XPC gene functions optimally, it helps prevent the development of mutations that could otherwise lead to cell death or uncontrolled cell growth. Because of its central role in maintaining DNA stability, variations in this gene are frequently investigated in the context of cancer research and pharmacogenomics.
Research and Associations
Research into rs2228000 has produced mixed and sometimes conflicting results regarding its clinical impact. Some studies have suggested that individuals carrying the T allele may have a slightly higher risk for certain types of cancer, such as bladder cancer or Hodgkin lymphoma, compared to those with the C allele. However, other large-scale studies have found no significant association between this variant and cancer risk, highlighting the complexity of genetic influences. In the field of pharmacogenomics, researchers have explored whether this variant affects how patients respond to DNA-damaging chemotherapy, as the efficiency of the NER pathway could theoretically influence treatment outcomes. Currently, the evidence linking this variant to specific clinical outcomes remains limited and inconsistent across different populations. It is important to note that cancer is a multifactorial disease, and genetic variants like rs2228000 are only one small piece of a much larger puzzle involving environmental and lifestyle factors.
Understanding Your Results
If you have received information about your rs2228000 genotype, it is essential to interpret it with caution. The scientific community has not established this variant as a definitive predictor of disease or a reliable marker for guiding medical treatment. Because the evidence is limited and often varies by ancestry, a specific genotype does not provide a clear medical diagnosis or a guaranteed outcome. You should never use this information to make decisions about your health, such as changing medications or skipping screenings, without consulting a qualified healthcare professional. If you are concerned about your cancer risk or how your body might respond to specific treatments, speak with your doctor or a genetic counselor. They can provide context based on your personal and family medical history, which is far more predictive than any single genetic variant.
How common is this variant?
The minor allele frequency for the T allele is approximately 0.35 globally, though it can reach up to 0.40 in South Asian populations.
Frequently asked questions
Does having the T allele mean I will get cancer?
No. Having a specific genotype for rs2228000 does not mean you will develop cancer. Most cancer cases are caused by a complex combination of environmental, lifestyle, and multiple genetic factors, not a single variant.
Should I change my chemotherapy based on this SNP?
You should never change your medication or treatment plan based on genetic test results without speaking to your oncologist. Always discuss your genetic information with your healthcare provider to determine if it is relevant to your specific clinical situation.
Is this variant the same as Xeroderma Pigmentosum?
No. While the XPC gene is associated with the rare condition Xeroderma Pigmentosum, that condition is typically caused by severe, rare mutations that significantly impair DNA repair. The rs2228000 variant is a common polymorphism and is not considered a cause of that condition.
Where can I find more reliable information about this SNP?
You can look at resources like the NIH's ClinVar or the GWAS Catalog for summaries of scientific research. These databases provide information on how specific variants have been studied in various populations.
Sources & further reading
Educational information only, last refreshed 9/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2228000?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29